The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for substantial growth and is projected to reach USD 13.4 billion by 2033. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback